Understanding how secreted proteins affect pancreatic islet function in type 2 diabetes
Identifying secreted protein networks affecting human pancreatic islet function in type 2 diabetes using public omic databases
This study is looking at how certain proteins affect the way pancreatic islet cells work together to control blood sugar, with the hope of finding new ways to help people with type 2 diabetes manage their condition better.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-10488268 on NIH RePORTER |
What this research studies
This research investigates the role of secreted proteins in the function of pancreatic islets, which are crucial for regulating blood sugar levels. By analyzing public omic databases, the study aims to uncover how these proteins influence the interaction between different types of islet cells in both healthy and diabetic states. The approach involves identifying specific proteins that may help improve islet function and, consequently, blood glucose control in individuals with type 2 diabetes. Patients may benefit from insights that could lead to new treatment strategies targeting these proteins.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults diagnosed with type 2 diabetes or those at risk of developing the condition.
Not a fit: Patients without type 2 diabetes or those with other forms of diabetes may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic targets for improving blood sugar control in patients with type 2 diabetes.
How similar studies have performed: Other research has shown promise in understanding the role of secreted proteins in metabolic diseases, suggesting that this approach could yield valuable insights.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Bhatnagar, Sushant — University of Alabama at Birmingham
- Study coordinator: Bhatnagar, Sushant
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.